128 related articles for article (PubMed ID: 23207573)
41. Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
Hinz R; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM
J Cereb Blood Flow Metab; 2007 Jan; 27(1):161-72. PubMed ID: 16685260
[TBL] [Abstract][Full Text] [Related]
42. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
Seeman P
Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
[TBL] [Abstract][Full Text] [Related]
43. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
[TBL] [Abstract][Full Text] [Related]
44. Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.
Ikoma Y; Ito H; Arakawa R; Okumura M; Seki C; Shidahara M; Takahashi H; Kimura Y; Kanno I; Suhara T
Neuroimage; 2008 Oct; 42(4):1285-94. PubMed ID: 18585466
[TBL] [Abstract][Full Text] [Related]
45. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
[TBL] [Abstract][Full Text] [Related]
46. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
[TBL] [Abstract][Full Text] [Related]
47. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
Tóth M; Varrone A; Steiger C; Laszlovszky I; Horváth A; Kiss B; Gyertyán I; Adham N; Halldin C; Gulyás B
Synapse; 2013 May; 67(5):258-64. PubMed ID: 23238770
[TBL] [Abstract][Full Text] [Related]
48. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
Boileau I; Nakajima S; Payer D
Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
[TBL] [Abstract][Full Text] [Related]
49. Quantification of dopamine D(2/3) receptors in rat brain using factor analysis corrected [18F]Fallypride images.
Millet P; Moulin-Sallanon M; Tournier BB; Dumas N; Charnay Y; Ibáñez V; Ginovart N
Neuroimage; 2012 Sep; 62(3):1455-68. PubMed ID: 22659483
[TBL] [Abstract][Full Text] [Related]
50. Spatio-temporal pharmacokinetic model based registration of 4D PET neuroimaging data.
Jiao J; Searle GE; Tziortzi AC; Salinas CA; Gunn RN; Schnabel JA
Neuroimage; 2014 Jan; 84():225-35. PubMed ID: 23994455
[TBL] [Abstract][Full Text] [Related]
51. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
[TBL] [Abstract][Full Text] [Related]
52. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO.
Payer DE; Behzadi A; Kish SJ; Houle S; Wilson AA; Rusjan PM; Tong J; Selby P; George TP; McCluskey T; Boileau I
Neuropsychopharmacology; 2014 Jan; 39(2):311-8. PubMed ID: 23921256
[TBL] [Abstract][Full Text] [Related]
53. Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride.
Ikoma Y; Watabe H; Hayashi T; Miyake Y; Teramoto N; Minato K; Iida H
Neuroimage; 2009 Oct; 47(4):1639-48. PubMed ID: 19520172
[TBL] [Abstract][Full Text] [Related]
54. Imaging the D3 receptor in humans in vivo using [11C](+)-PHNO positron emission tomography (PET).
Rabiner EA; Laruelle M
Int J Neuropsychopharmacol; 2010 Apr; 13(3):289-90. PubMed ID: 20149269
[No Abstract] [Full Text] [Related]
55. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
[TBL] [Abstract][Full Text] [Related]
57. Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.
Sóvágó J; Farde L; Halldin C; Langer O; Laszlovszky I; Kiss B; Gulyás B
Neurochem Int; 2004 Oct; 45(5):609-17. PubMed ID: 15234102
[TBL] [Abstract][Full Text] [Related]
58. Automated preparation of the dopamine D2/3 receptor agonist ligand [11C]-(+)-PHNO for human PET imaging studies.
Plisson C; Huiban M; Pampols-Maso S; Singleton G; Hill SP; Passchier J
Appl Radiat Isot; 2012 Feb; 70(2):380-7. PubMed ID: 22055845
[TBL] [Abstract][Full Text] [Related]
59. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
McCormick PN; Kapur S; Reckless G; Wilson AA
Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
[TBL] [Abstract][Full Text] [Related]
60. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
